|
MYD88 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.99480000295793E-08 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.02329999976492E-07 |
| Normal-vs-Stage2 |
3.299300E-03 |
| Normal-vs-Stage3 |
1.518190E-03 |
| Normal-vs-Stage4 |
5.377200E-01 |
| Stage1-vs-Stage2 |
8.237400E-01 |
| Stage1-vs-Stage3 |
2.282000E-01 |
| Stage1-vs-Stage4 |
5.584100E-04 |
| Stage2-vs-Stage3 |
3.136200E-01 |
| Stage2-vs-Stage4 |
1.348220E-02 |
| Stage3-vs-Stage4 |
6.683500E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.52739999981222E-07 |
| Normal-vs-AfricanAmerican |
4.39429999999907E-05 |
| Normal-vs-Asian |
1.539710E-02 |
| Caucasian-vs-AfricanAmerican |
9.807200E-01 |
| Caucasian-vs-Asian |
8.569600E-01 |
| AfricanAmerican-vs-Asian |
8.623600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.7339999980901E-08 |
| Normal-vs-Female |
2.00419999999424E-05 |
| Male-vs-Female |
8.093400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
3.158400E-02 |
| Normal-vs-Extreme_Weight |
3.84819999998953E-06 |
| Normal-vs-Obese |
6.25890000000018E-05 |
| Normal-vs-Extreme_Obese |
1.540020E-01 |
| Normal_Weight-vs-Extreme_Weight |
2.511600E-02 |
| Normal_Weight-vs-Obese |
7.559700E-02 |
| Normal_Weight-vs-Extreme_Obese |
4.587400E-01 |
| Extreme_Weight-vs-Obese |
7.177600E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.379200E-01 |
| Obese-vs-Extreme_Obese |
9.227200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.407400E-04 |
| Normal-vs-Age(41-60Yrs) |
5.56019996711399E-09 |
| Normal-vs-Age(61-80Yrs) |
1.61815999999426E-05 |
| Normal-vs-Age(81-100Yrs) |
1.193580E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.655400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.781800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.786600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.093600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.829000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.134600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.28770002941303E-10 |
| Normal-VS-Type2 PRCC |
2.394400E-02 |
| Normal-VS-KIRP CIMP |
2.762100E-02 |
| Normal-VS-Unclassified PRCC |
1.633760E-04 |
| Type1 PRCC-VS-Type2 PRCC |
3.54839999999745E-05 |
| Type1 PRCC-VS-KIRP CIMP |
7.041200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
9.911000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.329640E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.296700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
7.714600E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.395200E-04 |
| Normal-vs-N1 |
9.495500E-03 |
| Normal-vs-N2 |
6.641200E-01 |
| N0-vs-N1 |
7.378400E-01 |
| N0-vs-N2 |
2.967800E-01 |
| N1-vs-N2 |
3.996200E-01 |
|
|
